A new phase in the fight against Alzheimer's is underway, with some characterizing it as a "golden age" of research. New Alzheimer's drugs are being developed, which could potentially transform treatment, and an FDA advisory panel has backed one such drug, Leqembi, for Alzheimer's treatment. The progress in Alzheimer's research is being discussed by notable figures, including Bill Gates, who has also been addressing other health topics, such as HIV PrEP drugs.